The congress will constitute a unique occasion for specialised physicians, oncologists, scientists, industry representatives, patient advocates and nurses, from all around the world, to connect, and share their knowledge, experience, and research for the advancement of treatment of sarcoma and rare cancers.
The scientific and educational programme will feature insights into the diagnosis, prognostication, management and ongoing research of patients with rare adult solid cancers, including sessions on multidisciplinary expert management, targeted therapies, precision medicine, methodological challenges, policy and guidelines, as well as sessions specifically designed for young investigators.
We look forward to welcoming you again to Lugano in 2024, to share with you the latest original scientific data in these rare sub-entities.
- Jean-Yves Blay, Lyon, France
- Robin Jones, London, UK
- Claudia Valverde Morales, Barcelona, Spain